EUVIMEDEUVIMED entdecken
Crossref

Design of novel human microbiome-derived peptides for inhibition of OXA-48 Carbapenemase: An in-silico and in-vitro approach

Solmaz Sadeghi, Mohammad Ali Faramarzi, Maryam Siroosi

Microbial Pathogenesis · 2025

DOI: 10.1016/j.micpath.2025.107779 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbial Pathogenesis, 2025. Verfasst von Solmaz Sadeghi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Biotechnology, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran; Department of …. Hauptthemen laut MEDLINE: beta-Lactamases, Bacterial Proteins, Antimicrobial Peptides, beta-Lactamase Inhibitors. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 57 Literaturangaben. Gefördert von: Tehran University of Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

beta-LactamasesBacterial ProteinsAntimicrobial Peptidesbeta-Lactamase InhibitorsPeptidesHumansMolecular Docking SimulationMolecular Dynamics SimulationAnti-Bacterial AgentsMicrobial Sensitivity TestsDrug DesignComputer Simulation

Stichwörter der Autor:innen

Antibiotic resistanceDrug designOXA-48 carbapenemasePeptides

Substanzen

beta-LactamasesBacterial ProteinscarbapenemaseAnti-Bacterial AgentsAntimicrobial Peptidesbeta-Lactamase InhibitorsPeptides

Autor:innen und Institutionen

  • Department of Medical Biotechnology, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran; Department of Microbiology, School of Medicine, Tehran University of Medical Science…
  • Department of Pharmaceutical Biotechnology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.
  • Department of Microbiology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran. Electronic address: siroosim@sina.tums.ac.ir.

Förderung

  • Tehran University of Medical Sciences

Zitieren

APA

Sadeghi, S., Faramarzi, M. A., & Siroosi, M. (2025). Design of novel human microbiome-derived peptides for inhibition of OXA-48 Carbapenemase: An in-silico and in-vitro approach. Microbial Pathogenesis. https://doi.org/10.1016/j.micpath.2025.107779

Vancouver

Sadeghi S, Faramarzi MA, Siroosi M. Design of novel human microbiome-derived peptides for inhibition of OXA-48 Carbapenemase: An in-silico and in-vitro approach. Microbial Pathogenesis. 2025. doi:10.1016/j.micpath.2025.107779

BibTeX
@article{Sadeghi2025,
  author = {Sadeghi, Solmaz and Faramarzi, Mohammad Ali and Siroosi, Maryam},
  title = {Design of novel human microbiome-derived peptides for inhibition of OXA-48 Carbapenemase: An in-silico and in-vitro approach},
  journal = {Microbial Pathogenesis},
  year = {2025},
  doi = {10.1016/j.micpath.2025.107779}
}
Kostenlos starten →